{"id":"W2088169167","doi":"10.1097/cad.0b013e328331178f","title":"Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status","year":2009,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Institut National Du Cancer; Institute of Cancer Research; Institut National de la Santé et de la Recherche Médicale","keywords":"Docetaxel; Medicine; Internal medicine; Oncology; Hazard ratio; Breast cancer; Chemotherapy; Metastatic breast cancer; Trastuzumab; Univariate analysis; Cancer; Proportional hazards model; Confidence interval; Multivariate analysis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004459495,0.0005500986,0.001127044,0.0004298204,0.0001192749,0.00005351597,0.0003101302,0.0001307859,0.0003490452],"category_scores_gemma":[0.00005592607,0.0004370315,0.00008808972,0.001690773,0.0001897609,0.0004526313,0.00006368823,0.0007991,0.00001410293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00194733,"about_ca_system_score_gemma":0.0009561047,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01843726,"about_ca_topic_score_gemma":0.01530292,"domain_scores_codex":[0.9954588,0.000169199,0.0006982164,0.001152417,0.001313651,0.001207716],"domain_scores_gemma":[0.9980832,0.00008606771,0.0002572225,0.0006672236,0.000595713,0.0003106201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005803773,0.003547621,0.910733,0.0000629964,0.0001601976,0.0000762499,0.004121654,0.0001988497,0.00009385704,0.000002609345,0.00007466297,0.07512452],"study_design_scores_gemma":[0.02764392,0.0035754,0.9655339,0.0007562613,0.00004013214,0.000002768423,0.0005831208,0.0001332732,0.000937725,0.00004231864,0.0002681458,0.000483108],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897683,0.0004695916,0.000005245807,0.001633762,0.0001313769,0.00712311,0.0001909738,0.00008985265,0.0005878341],"genre_scores_gemma":[0.9938578,0.003133956,0.0001777808,0.0006387428,0.0001500449,0.001525879,0.00002231853,0.0000926162,0.0004008466],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07464141,"threshold_uncertainty_score":0.9998081,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01428580543352188,"score_gpt":0.3339744816509728,"score_spread":0.3196886762174509,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}